Across
- 1. approves drug indications
- 7. number of approved FDA indications for LIBTAYO
- 8. objective response rate. Duration of response. Complete response rate. Safety and tolerability.
- 11. action taken when a patient experiences a severe adverse reaction
- 15. administration method of LIBTAYO
- 16. Information resource that contains efficacy, safety, and usage information for LIBTAYO
- 18. method to confirm objective response rate (ORR)
- 19. color of LIBTAYO
- 20. the response restored by LIBTAYO
Down
- 2. 360 mg infusion, every 3 weeks
- 3. LIBTAYO biologic
- 4. immune function inhibited by LIBTAYO
- 5. Statistical method often used in evaluating PFS
- 6. criteria used to select patients for clinical trials
- 9. expresses programmed death receptor
- 10. generates fully human therapeutic antibodies, including LIBTAYO
- 12. LIBTAYO______ enhances patient access to LIBTAYO
- 13. profile in which adverse reactions are reported
- 14. first line immune response
- 16. organization of clinical trials
- 17. tumor staging criteria